FN Media Group News Commentary PALM BEACH, Fla., April 10, 2024 /PRNewswire/ -- With the increase in life expectancy, people need more medical help and care. AI-enabled technologies can help people to live healthier and longer lives. Artificial Intelligence (A.I.) has a great demand in the healthcare industry. Healthcare providers turn to tech companies for expertise in adopting AI, and naturally, demand for such expertise makes competition among the latter highly intensive.  A report from binariks.com pro ...

AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy DUBLIN, April 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care. GI Genius™ wa ...

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation SystemDUBLIN and BERLIN, April 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical trial safety and efficacy results for Sphere-360™, an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment of patients with paroxysmal atrial ...

New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien™ at one year DUBLIN and ATLANTA, April 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), were presented as a late breaking clinical trial at the American Coll ...

Core Insights - Medtronic's survey reveals significant gaps in awareness and referral for heart valve disease among women aged 50 and older, particularly those at risk for aortic stenosis [1][2][3] Awareness and Knowledge - 26% of women have not heard of common heart-related conditions, and only 30% of women aged 50 and older are aware of aortic stenosis [3] - Awareness is notably lower among women of color, with only 10% of Black women and 21% of Hispanic women aware of aortic stenosis compared to 33% of white women [3] Referral and Screening - 82% of women over 65 live with chronic conditions that increase their risk of aortic stenosis, yet 68% have never been referred to a cardiologist or undergone a heart disease risk assessment [3] Barriers to Seeking Care - Over 40% of women cite fear or anxiety about visiting a doctor, and 15% feel their symptoms will be dismissed [4] Treatment Preferences - 45% of women prioritize minimally invasive procedures when considering treatment options, indicating a strong interest in solutions like TAVR [5] - 75% of women are likely to inquire about more effective treatment options if presented with alternatives [5] Initiatives for Improvement - Medtronic and Women as One are launching educational campaigns and clinical trials to enhance health equity for women with heart valve disease [6] - The commitment to address healthcare inequities is emphasized through partnerships with clinical communities and organizations [6] Context on Aortic Stenosis - Aortic stenosis affects 1.5 million people in the U.S., with untreated symptomatic severe aortic stenosis leading to a two-year average survival rate [7] - Women face higher mortality rates from aortic stenosis compared to men, despite a longer life expectancy [7]

The most recent trading session ended with Medtronic (MDT) standing at $83.92, reflecting a -1.27% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of 1.23%. Meanwhile, the Dow experienced a drop of 1.36%, and the technology-dominated Nasdaq saw a decrease of 1.4%.Heading into today, shares of the medical device company had lost 0.64% over the past month, outpacing the Medical sector's loss of 1.23% and lagging the S&P 500's gain of 1.61% in that time.The investmen ...

Medtronic plc (MDT) recently secured the FDA’s approval for the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.The latest development will significantly boost the Coronary & Renal Denervation and Structural Heart & Aortic businesses, which are part of Medtronic’s Cardiovascular por ...

If you're an everyday investor looking for stocks that can deliver steadily rising dividend payouts over long periods, the healthcare sector is the right place to begin your search. People get sick during economic downturns just as often as they do when businesses are booming.Medtronic (MDT 0.27%) and Walgreens Boots Alliance (WBA 3.19%) are two dividend-paying giants of the healthcare sector. Both offer yields that are far more attractive than the paltry 1.4% yield you can receive from the average stock in ...

【商务部部长王文涛会见美敦力全球董事长兼首席执行官杰夫·马萨】3月24日，商务部部长王文涛会见美敦力全球董事长兼首席执行官杰夫·马萨。双方就全球医疗技术领域国际合作、美敦力在华发展等议题进行了交流。王文涛强调，中国医疗产业开放度高，发展潜力大，已成为全球第二大医疗器械市场。希望美敦力加大在华研发力度，引进更多前沿疗法、创新产品和服务，为健康中国贡献力量。杰夫·马萨表示，美敦力是第一批进入中国的跨国公司之一，近年来不断加大在华投资，引入更多高 科技产品和高端医疗设备，并计划在华新建创新中心，将为中国消费者带来更多优质产品。 ...

When you think of artificial intelligence (AI), you probably think of the technology companies creating the nuts and bolts that help AI come to life -- such as Nvidia's chips or Super Micro Computer's servers. We've already seen growth in these companies' earnings thanks to sales of their products to customers developing AI projects. They and some of their peers continue to make great investments because growth in the AI market looks like it's just getting started.But there's another way to invest in AI, an ...